ROOT Brands® Fills GLP-1 Gap with CRUSH™ & SCULPT™ After Ozempic® & Wegovy®

GLP-1 receptor agonists like Ozempic® and Wegovy® have transformed weight management, but a growing concern known as the "GLP-1 gap" highlights unmet needs in metabolic and muscle support. ROOT Brands®, led by Chief Science Officer Dr. Christina Rahm and CEO Clayton Thomas, positions CRUSH™ and SCULPT™ as a targeted, non-pharmaceutical protocol to bridge this gap. Designed for users during and after GLP-1 therapy, these products promote cellular health, lean muscle preservation, and sustained metabolic efficiency.

Understanding the GLP-1 Gap: Challenges After Ozempic® and Wegovy®

GLP-1 medications such as Ozempic® and Wegovy® excel at suppressing appetite, slowing gastric emptying, and regulating blood sugar, facilitating significant short-term weight loss. However, they were not formulated to address key aspects of long-term success, including preservation of lean muscle mass, enhancement of cellular energy production, or support for metabolic adaptability.

Clinical observations and consumer reports reveal a common pattern post-discontinuation: appetite rebounds rapidly, resting metabolic rate declines, lean body mass diminishes, and weight regain often follows swiftly. Digestive discomfort and low energy levels further complicate the transition. This "GLP-1 gap" underscores the need for nutritional strategies that operate at the cellular level to sustain results.

Why the GLP-1 Gap Matters for Metabolic Health

Maintaining lean muscle is crucial because it drives resting metabolic rate—muscle tissue burns more calories at rest than fat. GLP-1 drugs primarily target fat loss through caloric restriction but can inadvertently contribute to muscle catabolism without countermeasures. Addressing this gap supports not just weight maintenance but overall vitality, energy levels, and resilience against regain.

For patients, recognizing these limitations empowers proactive planning. Those on Ozempic® or Wegovy® should monitor body composition metrics like muscle mass via DEXA scans or bioimpedance scales, and consider integrating supportive nutrition early to mitigate risks.

The CRUSH™ and SCULPT™ Protocol: A Cellular-First Solution

ROOT Brands® developed CRUSH™ and SCULPT™ to provide clean, non-pharmaceutical support aligned with their "cellular-first" philosophy: Clean the cell. Feed the cell. Protect the cell. This approach emphasizes efficient nutrient utilization, mitochondrial function, and cellular health to complement GLP-1 therapy.

CRUSH™: Supporting Metabolic Function and Energy

CRUSH™ features seven essential amino acids in a stimulant-free formula. These building blocks of protein aid healthy metabolic function, cellular energy processes, and natural fat utilization. Essential amino acids are vital during caloric deficits from GLP-1 use, helping prevent muscle breakdown and supporting recovery for daily energy without crashes or dependency.

Patients transitioning off injections benefit from CRUSH™'s role in restoring metabolic efficiency, countering the dip in resting metabolic rate often seen post-GLP-1.

SCULPT™: Plant-Based Muscle and Composition Support

SCULPT™ incorporates clinically studied ingredients like InnoSlim®, Gymnema Sylvestre, White Kidney Bean extract, and Valerian Root. This plant-based formula targets lean muscle support, body composition balance, strength preservation, and metabolic resilience.

• InnoSlim®: Activates cellular pathways for glucose uptake and fat metabolism.
• Gymnema Sylvestre: Traditionally used to modulate sugar absorption.
• White Kidney Bean extract: Inhibits carb breakdown to aid composition goals.
• Valerian Root: Promotes relaxation and recovery.

Together, CRUSH™ and SCULPT™ form a protocol ideal for GLP-1 users seeking sustained outcomes.

Who Benefits from CRUSH™ and SCULPT™?

This protocol suits:

• Individuals currently using GLP-1 medications who want to support lean muscle and metabolic health.
• Those transitioning off GLP-1 medications seeking a non-pharmaceutical nutritional approach.
• People pursuing long-term body composition and metabolic support without injectable therapies.

Consult a healthcare provider before starting, especially if managing conditions like diabetes or gastrointestinal issues. Track progress with tools like symptom journals or apps such as Shotlee for monitoring energy, digestion, and side effects during transitions.

"GLP-1 medications can start the journey, but they were never intended to complete it," said Dr. Christina Rahm, Chief Science Officer of ROOT Brands®. "Long-term results require metabolic, muscular, and cellular support that goes beyond appetite suppression. CRUSH and SCULPT were created to help meet those needs."

"Search trends and consumer behavior make it clear-people recognize that something is missing after GLP-1," said Clayton Thomas, CEO of ROOT Brands®. "CRUSH and SCULPT were developed to support that moment and provide a structured, science-driven answer."

Safety and Practical Guidance for Integration

As non-drug supplements, CRUSH™ and SCULPT™ emphasize clean ingredients and transparent sourcing, minimizing interactions. Common GLP-1 side effects like nausea or fatigue may persist post-use; these products support digestive comfort and energy without stimulants.

Integration Tips:

• Start during GLP-1 use to build muscle buffers.
• Continue 4-8 weeks post-discontinuation for metabolic rebound prevention.
• Pair with resistance training and protein-rich meals for synergy.
• Monitor via regular check-ins with practitioners.

Compared to alternatives like isolated protein powders, this protocol's cellular focus and synergistic ingredients offer targeted GLP-1 gap coverage.

About ROOT Brands®

Based in Franklin, Tennessee, ROOT Brands® commits to science-driven, cellular-first nutrition. Under Dr. Christina Rahm and Clayton Thomas, products like CRUSH™, SCULPT™, Clean Slate™, Zero-In™, and Restore™ are distributed globally via independent partners, grounded in ingredient research.

Key Takeaways: Bridging the GLP-1 Gap

• GLP-1 drugs like Ozempic® and Wegovy® drive weight loss but leave metabolic and muscle gaps.
• CRUSH™ and SCULPT™ provide amino acid and plant-based support for cellular health and composition.
• Ideal for during, after, or instead of GLP-1 therapy.
• Emphasize doctor discussions and lifestyle integration for best results.

Conclusion: Sustainable Wellness Beyond Injections

The GLP-1 gap represents a pivotal opportunity for nutritional innovation. ROOT Brands® CRUSH™ and SCULPT™ empower users to sustain Ozempic® and Wegovy® gains through science-backed, cellular support. By addressing muscle preservation and metabolic resilience, this protocol fosters long-term body composition success—discuss with your provider to see if it's right for your journey.